Stay updated on Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial
Sign up to get notified when there's something new on the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page.

Latest updates to the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page
- CheckyesterdayChange DetectedA new funding identifier '2015 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH support for the trial.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing v3.6.4. This indicates a version update to the study page rather than a change to the study information itself.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision is updated from v3.6.3 to v3.6.4, indicating a newer revision of the Study Details page. This appears to be a routine metadata update that does not alter study content or user-facing information.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page's revision tag was bumped from v3.6.2 to v3.6.3, signaling a routine maintenance update. This platform-level change does not affect the study content or visible data.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0. This reflects an underlying update to the ClinicalTrials.gov interface rather than changes to study details.SummaryDifference0.0%

- Check74 days agoChange DetectedRecruitment status on the page indicates no longer looking for participants, effectively closing enrollment. The update also adds user help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment header with a new revision tag (Revision: v3.6.0).SummaryDifference0.4%

Stay in the know with updates to Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page.